← All patents

US20220347168A1

Lung targeted anticancer therapies with liposomal annamycin

University of Texas System

Abstract

Provided is a method of treating cancer cells localized in the lung by administering to such patients a therapeutically effective amount of a liposomal annamycin formulation (L-Ann).

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Waldemar Priebe
Priority date
November 21, 2019
Filing date
May 12, 2022
Publication date
November 03, 2022
Language
en
Metadata fetched
August 29, 2026 00:29